Additionally, using each gene list as a signature for KM analysis revealed that Nanos1-, Pum2-, and Cpsf4-responsive genes stratify DMFS for patients with the HER2-enriched subtype of breast cancer (Supplementary Fig. S2a–c). This evidence concerns the gene NANOS1 and breast cancer.